to break down 12.14.17 Looking back over the past year at the most read stories on CVSHealth.com, key themes that captured our readers attention included the opioid epidemic and prescription drug affordability. Both topics are not only trending on this website but are also pervasive on mainstream news outlets. In addition, these are areas where CVS Health has launched new efforts over the past year, and both will continue to be a focus for the company moving forward. In order of popularity, here are the most read articles over the past year. CVS Health Responds to Nation s Opioid Crisis : Opioid misuse and abuse have reached epidemic proportions. In September, CVS Health took bold steps to enhance its efforts to address the nation s crisis, including efforts to educate patients; ensure appropriate opioid use; increase access to appropriate medication disposal and fund community-based treatment and support. Protecting Consumers in an Environment of Rising Drug Prices : The high cost of prescriptions is becoming more commonplace and can jeopardize access to medications and put financial strain on patients and taxpayers. This article discusses how pharmacy benefit managers (PBMs) can help keep drug prices in check and keep out-of-pocket costs low for consumers through a variety of strategies and innovative programs. Time to Put Limits on Opioid Prescribing : This is a reprint of an op-ed for Morning Consult, authored by Larry Merlo, President and CEO of CVS Health, in July. In it, Mr. Merlo, called for limits on opioid prescribing and highlighted findings from a CVS Health survey , which found that nearly 1 in 3 people in the U.S. has been personally affected by this epidemic. Lowest Cash Price Epinephrine Auto-Injector Now Available at CVS Pharmacy : CVS Pharmacy announced that patients can now purchase the authorized generic for Adrenaclick , a Food and Drug Administration (FDA)-approved device with the same active ingredient as other epinephrine auto-injector devices, at the lowest cash price in the market. Promoting Competition to Reduce Drug Spending : A panel of experts at The Brookings Institute, including CVS Health Chief Policy and External Affairs Officer and General Counsel Tom Moriarty, weighed in on the pharmaceutical supply chain and the critical role that generic medications and biosimilars play in keeping rising drug prices in check and driving value for the system. Naloxone availability across the United States 4 6 See States Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin CVS Pharmacy patients in 46 states now have access to the opioid overdose-reversal drug, naloxone. Follow our commitment to drug abuse prevention as we increase access to the life-saving opioid overdose reversal drug. Related Articles Experts Discuss Opioid Epidemic at Forbes Healthcare Summit CVS Health s CMO Troy Brennan and expert panel discuss solutions to curb the opioid epidemic and assist those already facing addiction. CVS Health and POLITICO Examine the Opioid Crisis A quick and easy-to-understand explanation of one of the most pressing challenges in public health: the opioid epidemic. Tackling the Nation s Opioid Crisis: POLITICO Pro Health Care Briefing Experts weigh in with personal experiences and multifaceted solutions to addressing the opioid crisis in America. Related Press Releases 09.21.17 CVS Health Fighting National Opioid Abuse Epidemic With Enterprise Initiatives 09.12.17 CVS Health Makes Overdose-Reversal Drug Available Without Individual Prescription at CVS Pharmacy Locations in Kansas 07.27.17 CVS Health Makes Overdose-Reversal Drug Available Without Individual Prescription at CVS Pharmacy Locations in South Dakota 05.23.17 Attorney General Brnovich, Rep. Carter Join CVS Health to Announce Availability of Naloxone at All CVS Pharmacy Locations in Arizona 04.27.17 CVS Health Report Examines Public Perceptions of Opioid Epidemic, Drug Disposal Ahead of National Prescription Drug Take Back Day 03.29.17 Reynolds, State Officials and CVS Health Announce Availability of Naloxone at All CVS Pharmacy Locations in Iowa in recent times
TOP Products Year in Review: The Top 5 Stories of 2017 deadlock
EmoticonEmoticon